Role of cranial radiotherapy for childhood T-cell acute lymphoblastic leukemia with high WBC count and good response to prednisone. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster groups.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Journal of Clinical Oncology

• Publication date

  1997-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.1997.15.8.2786PMID 9256120
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Good steroid response in vivo predicts a favorable outcome in children with T‐cell acute lymphoblastic leukemia

  1995cited by this paper
• High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia.

  1995cited by this paper
• Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica.

  1995cited by this paper
• Good steroid response in vivo predicts a favorable outcome in children with T-cell acute lymphoblastic leukemia. The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP).

  1995cited by this paper
• [Concept and interim result of the ALL-BFM 90 therapy study in treatment of acute lymphoblastic leukemia in children and adolescents: the significance of initial therapy response in blood and bone marrow].

  1994cited by this paper
• Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86.

  1994cited by this paper
• Current status of cytogenetic research in childhood acute lymphoblastic leukemia.

  1993cited by this paper
• Current Status of Cytogenetic Research in Childhood Acute Lymphoblastic Leukemia

  1993cited by this paper
• Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia.

  1993cited by this paper
• Prevention of CNS disease in intermediate-risk acute lymphoblastic leukemia: comparison of cranial radiation and intrathecal methotrexate and the importance of systemic therapy: a Childrens Cancer Group report.

  1993cited by this paper
• Treatment of acute lymphoblastic leukemia. 30 years' experience at St. Jude Children's Research Hospital.

  1993cited by this paper
• Incidence and prognostic significance of immunophenotypic subgroups in childhood acute lymphoblastic leukemia: the experience of the AIEOP Cooperative Study. Associazione Italiana Ematologia Oncologia Pediatrica.

  1993cited by this paper
• Does cranial irradiation reduce the risk for bone marrow relapse in acute myelogenous leukemia? Unexpected results of the Childhood Acute Myelogenous Leukemia Study BFM-87.

  1993cited by this paper
• Extended triple intrathecal chemotherapy trial for prevention of CNS relapse in good-risk and poor-risk patients with B-progenitor acute lymphoblastic leukemia: a Pediatric Oncology Group study.

  1993cited by this paper
• Current results of studies of immunophenotype-, age- and leukocyte-based therapy for children with acute lymphoblastic leukemia. The Pediatric Oncology Group.

  1992cited by this paper
• Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: a Pediatric Oncology Group study.

  1992cited by this paper
• Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM group.

  1991cited by this paper
• [Incidence, clinical markers and prognostic significance of immunologic subtypes of acute lymphoblastic leukemia (ALL) in children: experiences of the ALL-BFM 83 and 86 studies].

  1990cited by this paper
• Heterogeneity of presenting features and their relation to treatment outcome in 120 children with T-cell acute lymphoblastic leukemia.

  1990cited by this paper
• Prognostic factors in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study

  1990cited by this paper
• Prognostic factors in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study.

  1990cited by this paper
• Results and significance of six randomized trials in four consecutive ALL-BFM studies.

  1990cited by this paper
• Treating childhood acute lymphoblastic leukaemia (ALL): summary of ten years' experience in Italy. ALL Steering Committee of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP).

  1989cited by this paper
• Die Corticosteroid-abhängige Dezimierung der Leukämiezellzahl im Blut als Prognosefaktor bei der akuten lymphoblastischen Leukämie im Kindesalter (Therapiestudie ALL-BFM 83)

  1987cited by this paper
• [Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83)].

  1987cited by this paper
• Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia.

  1986cited by this paper
• The Statistical Analysis of Failure Time Data

  1980cited by this paper
• Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative Group

  1976cited by this paper

• Effect of two additional doses of intrathecal methotrexate during induction therapy on serious infectious toxicity in pediatric patients with acute lymphoblastic leukemia

  2023cites this paper
• Identification of prognostic factors in childhood T‐cell acute lymphoblastic leukemia: Results from DFCI ALL Consortium Protocols 05‐001 and 11‐001

  2020cites this paper
• High TUBB2A expression in childhood T‐ALL is correlated with the clinical outcome

  2020cites this paper
• Is the blood–brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data

  2018cites this paper
• Advanced Multimodal Methods for Cranial Pseudo-CT Generation Validated by IMRT and VMAT Radiation Therapy Plans.

  2018cites this paper
• L-Asparaginase Isolated from Phaseolus vulgaris Seeds Exhibited Potent Anti-Acute Lymphoblastic Leukemia Effects In-Vitro and Low Immunogenic Properties In-Vivo

  2016cites this paper
• Outcome of Children with Standard‐Risk T‐Lineage Acute Lymphoblastic Leukemia—Comparison among Different Treatment Strategies

  2016cites this paper
• Treatment of children with acute lymphoblastic leukemia with risk group based intensification and omission of cranial irradiation: A Korean study of 295 patients

  2016cites this paper
• The Effect of Intensive Intrathecal Chemotherapy on Prognosis of Childhood Lymphoblastic Leukemia with Central Nervous System Involvement: A 20-Year Experience

  2016cites this paper
• An investigation into the role of receptor tyrosine kinases in childhood Acute Lymphoblastic Leukaemia

  2014influential citation
• Leukemia Central Nervous System Relapse in Children With Acute Lymphoblastic Early Intensification of Intrathecal Chemotherapy Virtually Eliminates

  2013cites this paper
• Hospital results of Total Therapy Study XIIIB at St Jude Children's Research Improved outcome for children with acute lymphoblastic leukemia:

  2013cites this paper
• Treatment of Adolescents and Young Adults with Acute Lymphoblastic Leukemia Children’s Cancer Group Trials

  2012cites this paper
• Effectiveness of high-dose methotrexate in T-cell lymphoblastic leukemia and advanced-stage lymphoblastic lymphoma: a randomized study by the Children's Oncology Group (POG 9404).

  2011cites this paper
• T-Cell Acute Lymphoblastic Leukemia

  2011cites this paper
• Current Treatment Approaches in Childhood Acute Lymphoblastic Leukemia

  2010cites this paper
• Cooperative study group for childhood acute lymphoblastic leukaemia (COALL): long-term results of trials 82,85,89,92 and 97

  2010cites this paper
• The Role of Radiation Therapy in Childhood Acute Leukemia A Review from the Viewpoint of Basic and Clinical Radiation Oncology

  2010cites this paper
• 54 – Pediatric Leukemias and Lymphomas

  2010cites this paper
• Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia

  2010cites this paper
• Aspects of Early Detection of Testicular Cancer and Cancer-Related Infertility

  2010cites this paper
• Treatment including intrathecal chemotherapy with and without cranial irradiation for prevention of central nervous system relapse of childhood acute lymphoblastic leukemia

  2010cites this paper
• Long-term results of the Israeli National Studies in childhood acute lymphoblastic leukemia: INS 84, 89 and 98

  2010cites this paper
• Treating childhood acute lymphoblastic leukemia without cranial irradiation.

  2009cites this paper
• Extended triple intrathecal therapy in children with T‐cell acute lymphoblastic leukaemia: a report from the Israeli National ALL‐Studies

  2009cites this paper
• Treatment of childhood acute lymphoblastic leukemia.

  2009cites this paper
• Risk-adapted treatment of pediatric acute lymphoblastic leukemia.

  2009cites this paper
• Clofarabine, cyclophosphamide and etoposide as single‐course re‐induction therapy for children with refractory/multiple relapsed acute lymphoblastic leukaemia

  2009cites this paper
• Central nervous system disease in hematologic malignancies: historical perspective and practical applications.

  2009cites this paper
• The Impact of Acute Lymphoblastic Leukemia Treatment on Central Nervous System Results in Bogota, Colombia

  2008cites this paper
• Improved outcome for children with acute lymphoblastic leukemia after risk-adjusted intensive therapy: a single-institution experience

  2008cites this paper
• Efficacy and safety of intrathecal liposomal cytarabine for the treatment of meningeal relapse in acute lymphoblastic leukemia: Experience of two pediatric institutions

  2008cites this paper
• Current management and challenges of malignant disease in the CNS in paediatric leukaemia.

  2008cites this paper
• Oncogenes and prognosis in childhood T-cell acute lymphoblastic leukaemia

  2008cites this paper
• Treatment of pediatric acute lymphoblastic leukemia

  2008cites this paper
• Pulses of vincristine and dexamethasone in addition to intensive chemotherapy for children with intermediate-risk acute lymphoblastic leukaemia: a multicentre randomised trial.

  2007cites this paper
• Moyamoya syndrome following childhood acute lymphoblastic leukemia

  2007cites this paper
• Central nervous system disease in acute lymphoblastic leukemia: prophylaxis and treatment.

  2006cites this paper
• Akute lymphoblastische Leukämien

  2006cites this paper
• Leucémies aiguës lymphoblastiques de l’enfant

  2006cites this paper
• Acute Lymphoblastic Leukemia: Current Treatment

  2005cites this paper
• Treatment reduction in highly selected standard-risk childhood acute lymphoblastic leukemia. The AIEOP ALL-9501 study.

  2005cites this paper
• Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital.

  2004cites this paper
• CNS‐directed therapy in young children with T‐lineage acute lymphoblastic leukemia: High‐dose methotrexate versus cranial irradiation

  2004cites this paper
• RISK ASSESSMENT IN CHILDHOOD AND ADOLESCENT ACUTE LYMPHOBLASTIC LEUKEMIA

  2004cites this paper
• Childhood and adolescent lymphoid and myeloid leukemia.

  2004cites this paper
• Acute lymphoblastic leukaemia

  2004cites this paper
• Methotrexate Infusions as Central Nervous System Prophylaxis in Children with Acute Lymphocytic Leukemia: The Norwegian Experience

  2003cites this paper
• Methotrexate infusions as central nervous system prophylaxis in children with acute lymphocytic leukemia: the Norwegian experience.

  2003cites this paper
• Diagnosis, Prophylaxis, and Treatment of Central Nervous System Involvement in Acute Lymphoblastic Leukemia

  2003cites this paper
• Etoposide in Acute Leukemias

  2003cites this paper
• Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience.

  2003cites this paper
• Treatment of Acute Leukemias

  2003influential citation
• Childhood acute lymphoblastic leukemia.

  2002cites this paper
• Nouvelles approches dans le traitement des leucémies aiguës de l'enfant

  2002cites this paper
• BFM-oriented treatment for children with acute lymphoblastic leukemia without cranial irradiation and treatment reduction for standard risk patients: results of DCLSG protocol ALL-8 (1991–1996)

  2002cites this paper
• Treatment of acute leukemias : new directions for clinical research

  2002influential citation
• International childhood Acute Lymphoblastic Leukemia workshop: Sausalito, CA, 30 November–1 December 2000

  2001cites this paper
• Childhood acute lymphoblastic leukaemia--current status and future perspectives.

  2001cites this paper
• Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report

  2000cites this paper
• Recent advances in management of acute leukaemia

  2000cites this paper
• Acute neurotoxicity in children with B-lineage acute lymphoblastic leukemia (B-ALL) treated with intermediate risk protocols.

  2000cites this paper
• Long-term follow-up of Dutch Childhood Leukemia Study Group (DCLSG) protocols for children with acute lymphoblastic leukemia, 1984–1991

  2000cites this paper
• Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report. Children Leukemia Cooperative Group.

  2000cites this paper
• Effective preventive central nervous system therapy with extended triple intrathecal therapy and the modified ALL‐BFM 86 chemotherapy program in an enlarged non‐high risk group of children and adolescents with non‐B‐cell acute lymphoblastic leukemia

  2000cites this paper
• Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Acute Lymphoblastic Leukemia Studies, 1982–1995

  2000cites this paper
• Regional Chemotherapy

  2000cites this paper
• Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995

  2000cites this paper
• Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group.

  2000cites this paper
• Regional Chemotherapy for Treatment and Prophylaxis of Meningeal Leukemia

  2000cites this paper
• THE MANAGEMENT OF HIGH‐RISK LYMPHOBLASTIC LEUKAEMIA IN CHILDREN

  2000cites this paper
• Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Münster.

  2000cites this paper
• Effects of cranial radiation in children with high risk T cell acute lymphoblastic leukemia: a Pediatric Oncology Group report

  2000cites this paper
• Cerebrospinal fluid asparagine concentrations after Escherichia coli asparaginase in children with acute lymphoblastic leukemia.

  1999cites this paper
• Wilms' tumour gene (wt1) expression at diagnosis has no prognostic relevance in childhood acute lymphoblastic leukaemia treated by an intensive chemotherapy protocol

  1999cites this paper
• Intensive treatment of children with acute lymphoblastic leukemia according to ALL-BFM-86 without cranial radiotherapy: results of Dutch Childhood Leukemia Study Group Protocol ALL-7 (1988-1991).

  1999cites this paper
• Treatment results in childhood acute lymphoblastic leukemia with a modified ALL-BFM'90 protocol: lack of improvement in high-risk group.

  1999cites this paper
• Prevention of CNS recurrence in childhood ALL: Results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trials

  1998cites this paper
• Philadelphia chromosome-positive (Ph+) childhood acute lymphoblastic leukemia: good initial steroid response allows early prediction of a favorable treatment outcome.

  1998cites this paper
• Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica.

  1998cites this paper
• Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP).

  1998cites this paper
• Prophylaxis and treatment of neoplastic meningeosis in childhood acute lymphoblastic leukemia

  1998cites this paper
• Acute lymphoblastic leukemia.

  1998cites this paper
• Early intensification of intrathecal chemotherapy virtually eliminates central nervous system relapse in children with acute lymphoblastic leukemia.

  1998cites this paper
• Chromosome-Positive ( Ph 1 ) Childhood Acute Lymphoblastic Leukemia : Good Initial Steroid Response Allows Early Prediction of a Favorable Treatment Outcome

  1998cites this paper
• Clinical relevance of CD10 expression in childhood ALL RITA CONSOLINI,* ANNALISA LEGITIMO,* ROBERTO RONDELLI,° CESARE GUGLIELMI,# ELENA BARISONE,@ ALMA LIPPI,^ ANGELO CANTÙ-RAJNOLDI,§ MAURIZIO ARICÒ,** VALENTINO CONTER,§ MARIA GRAZIA COCITO,°° MARIA CATERINA PUTTI,°° ANDREA PESSION,° GIUSEPPE MASE

  1998cites this paper
• Expression of myeloid markers lacks prognostic impact in children treated for acute lymphoblastic leukemia: Italian experience in AIEOP-ALL 88-91 studies.

  1998cites this paper
• Childhood Acute Lymphoblastic Leukemia.

  1997cites this paper